Umb Bank, N.A. Collegium Pharmaceutical, Inc Transaction History
Umb Bank, N.A.
- $6.3 Billion
- Q3 2024
A detailed history of Umb Bank, N.A. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 78 shares of COLL stock, worth $2,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 39
100.0%
Holding current value
$2,410
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
256Shares Held
38.6MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$179 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$81.4 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$80 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$72.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.75MShares$53.9 Million0.04% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.05B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...